Literature DB >> 32024979

B cells and TLSs facilitate a response to ICI.

Diana Romero1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32024979     DOI： 10.1038/s41571-020-0338-6

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  5 in total

1.  IgD ligation allows peritoneal cavity B cell proliferation.

Authors:  Jennifer Londregan; Jeffrey Maslanka; Naomi Goldman; John Somerville; James E Riggs
Journal:  Immunobiology       Date:  2022-01-20       Impact factor: 3.144

2.  Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer.

Authors:  Jieqiong Liu; Ying Wang; Zhenluan Tian; Ying Lin; Hengyu Li; Zhaowen Zhu; Qiang Liu; Shicheng Su; Yinduo Zeng; Weijuan Jia; Yaping Yang; Shengqiang Xu; Herui Yao; Wen Jiang; Erwei Song
Journal:  Nat Commun       Date:  2022-05-31       Impact factor: 17.694

Review 3.  Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy.

Authors:  Tao Wang; Desirée Denman; Silvia M Bacot; Gerald M Feldman
Journal:  Biomedicines       Date:  2022-05-20

Review 4.  Next-Generation Immunotherapies to Improve Anticancer Immunity.

Authors:  Yaoyao Shi; Katarzyna Tomczak; June Li; Joshua K Ochieng; Younghee Lee; Cara Haymaker
Journal:  Front Pharmacol       Date:  2021-01-11       Impact factor: 5.810

5.  Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.

Authors:  Romain Banchereau; Avantika S Chitre; Alexis Scherl; Thomas D Wu; Namrata S Patil; Sanjeev Mariathasan; Jane Grogan; William E O'Gorman; Patricia de Almeida; Edward E Kadel Iii; Shravan Madireddi; Amelia Au-Yeung; Chikara Takahashi; Ying-Jiun Chen; Zora Modrusan; Jacqueline McBride; Rhea Nersesian; Ehab A El-Gabry; Mark D Robida; Jeffrey C Hung; Marcin Kowanetz; Wei Zou; Mark McCleland; Patrick Caplazi; Shadi Toghi Eshgi; Hartmut Koeppen; Priti S Hegde; Ira Mellman; W Rodney Mathews; Thomas Powles
Journal:  J Immunother Cancer       Date:  2021-04       Impact factor: 13.751
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.